TRANSMEDICS GROUP INC

TRANSMEDICS GROUP INC

Share · US89377M1099 · TMDX (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of TRANSMEDICS GROUP INC
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
9
3
0
0
No Price
29.04.2026 19:31
Current Prices from TRANSMEDICS GROUP INC
ExchangeTickerCurrencyLast TradePriceDaily Change
IEXG: IEX
IEX
TMDX
USD
29.04.2026 19:31
98,07 USD
-3,19 USD
-3,15 %
XNAS: NASDAQ
NASDAQ
TMDX
USD
29.04.2026 19:16
98,91 USD
-2,35 USD
-2,32 %
XHAM: Hamburg
Hamburg
TMGIRS99.HAMB
EUR
29.04.2026 06:11
87,04 EUR
-7,04 EUR
-7,48 %
XDQU: Quotrix
Quotrix
TMGIRS99.DUSD
EUR
29.04.2026 05:27
86,64 EUR
-7,44 EUR
-7,91 %
XDUS: Düsseldorf
Düsseldorf
TMGIRS99.DUSB
EUR
28.04.2026 17:31
86,24 EUR
-7,84 EUR
-8,33 %
Share Float & Liquidity
Free Float 96,09 %
Shares Float 33,19 M
Shares Outstanding 34,54 M
Invested Funds

The following funds have invested in TRANSMEDICS GROUP INC:

Fund
iShares US Medical Devices UCITS ETF USD (Acc)
Vol. in million
24,22
Percentage (%)
0,04 %
Company Profile for TRANSMEDICS GROUP INC Share
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Company Data

Name TRANSMEDICS GROUP INC
Company TransMedics Group, Inc.
Symbol TMDX
Website https://www.transmedics.com
Primary Exchange XNAS NASDAQ
ISIN US89377M1099
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Waleed H. Hassanein
Market Capitalization 3 Mrd.
Country United States of America
Currency USD
Employees 0,7 T
Address 200 Minuteman Road, 01810 Andover
IPO Date 2019-05-02

Ticker Symbols

Name Symbol
Düsseldorf TMGIRS99.DUSB
Frankfurt 8T8.F
Hamburg TMGIRS99.HAMB
NASDAQ TMDX
Quotrix TMGIRS99.DUSD
More Shares
Investors who hold TRANSMEDICS GROUP INC also have the following shares in their portfolio:
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Share
AMAZON.CO INC
AMAZON.CO INC Share
AMGEN INC
AMGEN INC Share
ASIAN DEV. BK 19/25 MTN
ASIAN DEV. BK 19/25 MTN Bond
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
EM-Tech.CO., Ltd.
EM-Tech.CO., Ltd. Share
ENERGIZER .NEW
ENERGIZER .NEW Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
PAYPAL INC
PAYPAL INC Share
STARBUCKS CORP
STARBUCKS CORP Share
VONTOBEL-GL EQ.B-DL
VONTOBEL-GL EQ.B-DL Fund
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share